Literature DB >> 25773753

On the criteria used for assessing the risk of bias in randomized trials included in systematic reviews and meta-analyses addressing adverse effects.

Stefanos Bonovas1, Theodore Lytras, Georgios Nikolopoulos.   

Abstract

Mesh：

Year:  2015        PMID： 25773753     DOI： 10.1007/s10654-015-0015-8

Source DB:  PubMed          Journal:  Eur J Epidemiol        ISSN： 0393-2990            Impact factor:   8.082


× No keyword cloud information.
  6 in total

1.  Adverse drug reactions in current antihypertensive therapy: a general practice survey of 2586 patients in Norway.

Authors:  H Olsen; T Klemetsrud; H P Stokke; S Tretli; A Westheim
Journal:  Blood Press       Date:  1999       Impact factor: 2.835

2.  Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement.

Authors:  David Moher; Alessandro Liberati; Jennifer Tetzlaff; Douglas G Altman
Journal:  Ann Intern Med       Date:  2009-07-20       Impact factor: 25.391

Review 3.  Adverse effects of biologics: a network meta-analysis and Cochrane overview.

Authors:  Jasvinder A Singh; George A Wells; Robin Christensen; Elizabeth Tanjong Ghogomu; Lara Maxwell; John K Macdonald; Graziella Filippini; Nicole Skoetz; Damian Francis; Luciane C Lopes; Gordon H Guyatt; Jochen Schmitt; Loredana La Mantia; Tobias Weberschock; Juliana F Roos; Hendrik Siebert; Sarah Hershan; Michael Pt Lunn; Peter Tugwell; Rachelle Buchbinder
Journal:  Cochrane Database Syst Rev       Date:  2011-02-16

Review 4.  Systemic safety of bevacizumab versus ranibizumab for neovascular age-related macular degeneration.

Authors:  Lorenzo Moja; Ersilia Lucenteforte; Koren H Kwag; Vittorio Bertele; Annalisa Campomori; Usha Chakravarthy; Roberto D'Amico; Kay Dickersin; Laurent Kodjikian; Kristina Lindsley; Yoon Loke; Maureen Maguire; Daniel F Martin; Alessandro Mugelli; Bernd Mühlbauer; Isabel Püntmann; Barnaby Reeves; Chris Rogers; Christine Schmucker; Manju L Subramanian; Gianni Virgili
Journal:  Cochrane Database Syst Rev       Date:  2014-09-15

5.  Influence of reported study design characteristics on intervention effect estimates from randomized, controlled trials.

Authors:  Jelena Savović; Hayley E Jones; Douglas G Altman; Ross J Harris; Peter Jüni; Julie Pildal; Bodil Als-Nielsen; Ethan M Balk; Christian Gluud; Lise Lotte Gluud; John P A Ioannidis; Kenneth F Schulz; Rebecca Beynon; Nicky J Welton; Lesley Wood; David Moher; Jonathan J Deeks; Jonathan A C Sterne
Journal:  Ann Intern Med       Date:  2012-09-18       Impact factor: 25.391

Review 6.  Corticosteroids and risk of gastrointestinal bleeding: a systematic review and meta-analysis.

Authors:  Sigrid Narum; Tone Westergren; Marianne Klemp
Journal:  BMJ Open       Date:  2014-05-15       Impact factor: 2.692
  6 in total
  4 in total

1.  Comparative assessment of budesonide-MMX and mesalamine in active, mild-to-moderate ulcerative colitis: A systematic review and network meta-analysis.

Authors:  Stefanos Bonovas; Georgios K Nikolopoulos; Daniele Piovani; Marien González-Lorenzo; Katerina Pantavou; Theodore Lytras; Laurent Peyrin-Biroulet; Silvio Danese
Journal:  Br J Clin Pharmacol       Date:  2019-07-31       Impact factor: 4.335

2.  Comparative safety of systemic and low-bioavailability steroids in inflammatory bowel disease: Systematic review and network meta-analysis.

Authors:  Stefanos Bonovas; Georgios K Nikolopoulos; Theodore Lytras; Gionata Fiorino; Laurent Peyrin-Biroulet; Silvio Danese
Journal:  Br J Clin Pharmacol       Date:  2017-12-01       Impact factor: 4.335

3.  Assessing the efficacy and safety of fecal microbiota transplantation and probiotic VSL#3 for active ulcerative colitis: A systematic review and meta-analysis.

Authors:  Xiaofei Dang; Mingjie Xu; Duanrui Liu; Dajie Zhou; Weihua Yang
Journal:  PLoS One       Date:  2020-03-17       Impact factor: 3.240

Review 4.  Intravenous Versus Oral Iron for the Treatment of Anemia in Inflammatory Bowel Disease: A Systematic Review and Meta-Analysis of Randomized Controlled Trials.

Authors:  Stefanos Bonovas; Gionata Fiorino; Mariangela Allocca; Theodore Lytras; Argirios Tsantes; Laurent Peyrin-Biroulet; Silvio Danese
Journal:  Medicine (Baltimore)       Date:  2016-01       Impact factor: 1.817
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.